Clinical Report: Building Consistency into NGS Workflows for Cancer Sample Profiling

Overview

The Magnis NGS Prep System streamlines next-generation sequencing (NGS) library preparation with minimal hands-on time and integrated quality control. This system supports comprehensive genomic profiling for cancer samples, enhancing reproducibility and consistency in results.

Background

Next-generation sequencing has revolutionized cancer diagnostics by enabling detailed genomic profiling. The ability to efficiently prepare sequencing-ready libraries from low DNA or RNA inputs is crucial for accurate detection of somatic variants in tumors. Standardized workflows, such as those provided by the Magnis NGS Prep System, are essential for ensuring reliable results in clinical settings.

Data Highlights

The Magnis NGS Prep System requires only 15 minutes of hands-on time and is compatible with SureSelect Cancer assays for tumor genomic profiling.

Key Findings

• The Magnis NGS Prep System automates NGS library preparation, improving workflow efficiency.
• Integrated quality control steps enhance reproducibility and consistency in genomic profiling.
• The system can work with as little as 10 ng of DNA or RNA, making it accessible for various sample types.
• Comprehensive genomic profiling can inform treatment decisions and improve patient outcomes.
• Standardized test designs and expert review are critical for the effective implementation of NGS in oncology.

Clinical Implications

The Magnis NGS Prep System offers a practical solution for laboratories looking to implement efficient and reliable NGS workflows. By ensuring high-quality genomic profiling, clinicians can make more informed treatment decisions based on comprehensive genomic data.

Conclusion

The integration of automated NGS workflows like the Magnis NGS Prep System is vital for advancing cancer diagnostics and treatment. Enhanced consistency and reproducibility in genomic profiling will ultimately support better patient management.

References

1. Blood Cancer Journal, 2013 -- Insights Gained from Next-Generation Sequencing in Blood Cancers
2. The ASCO Post, 2014 -- Expert Panels Offer Five Proposals to Address Challenges in Regulating, Implementing Next-Generation Sequencing
3. the pathologist, 2026 -- Implementation of a large liquid biopsy genomic profiling assay in a decentralized setting
4. Somatic Genomic Testing in Patients With Metastatic or Advanced Cancer: ASCO Provisional Clinical Opinion - PubMed, 2025
5. Real-world clinical utility of comprehensive genomic profiling in advanced solid tumors | Nature Medicine, 2025
6. Acta Neuropathologica — Rapid Genomic and Epigenomic Assessment of Brain Tumors via Real-Time Nanopore Sequencing
7. Somatic Genomic Testing in Patients With Metastatic or Advanced Cancer: ASCO Provisional Clinical Opinion - PubMed
8. Real-world clinical utility of comprehensive genomic profiling in advanced solid tumors | Nature Medicine
9. https://documents.cap.org/documents/2025_Checklist_Summary.pdf